Recognizing David Sparks for Contributions to Pharmaceutical Industry


Mr. CARTER of Georgia. Mr. Speaker, I rise today to recognize David  Sparks for his outstanding contributions and visionary leadership in  the pharmaceutical industry.

As the previous CEO and current chairman of the board at the  Professional Compounding Centers of America, PCCA, Mr. Sparks has been  instrumental in advancing the pharmaceutical industry. Since joining  PCCA in 1992, he has fought to protect pharmacists' rights to compound,  playing a key role in FDA reform legislation. Before PCCA, he owned  pharmacies in Tulsa for over two decades, pioneering the introduction  of compounding pharmacies in hospice care.

Committed to education, Mr. Sparks is a proud contributor to the  SWOSU general scholarship fund, ensuring that future pharmacists have  the essential resources to succeed. He is also an adjunct professor at  the University of Houston College of Pharmacy and an active member of  its Mading Society of benefactors. He remains a dedicated advocate for  the advancement of pharmacy, continuously supporting the profession  through leadership and philanthropy.

Mr. Sparks' impact on the pharmaceutical industry is profound and  lasting, and his leadership will continue to shape its future.      Recognizing Jim Smith for Leadership in Pharmaceutical Compounding

Mr. CARTER of Georgia. Mr. Speaker, I rise today to recognize Jim  Smith, a distinguished leader whose dedication and vision have  profoundly impacted both the Professional Compounding Centers of  America, PCCA, and the healthcare industry.

His educational background, including a bachelor of science in  chemistry and biology from West Texas A&M University and an MBA from  the University of Portland, has shaped his strategic leadership.

Since joining PCCA in 2000, Mr. Smith has played a crucial role in  the organization's growth, serving as president, chief operating  officer, vice president of sales and marketing, and a key member of the  strategic management team. His leadership has strengthened PCCA's core  capabilities, driving innovation and excellence in pharmaceutical  compounding.

Prior to his tenure, Mr. Smith leveraged his expertise in home  health, specialty medicine, respiratory pharmacy, long-term care  pharmacy, and compounding support, demonstrating his commitment to  advancing patient care.

Today, as executive adviser to the PCCA board of directors, Mr. Smith  continues to shape the industry, ensuring that innovation and patient  care remain at the forefront.

Mr. Smith's dedication exemplifies the highest standards of  leadership and service.    Congratulating Gus Bassani, a Visionary in Pharmaceutical Compounding

Mr. CARTER of Georgia. Mr. Speaker, I rise today to congratulate Gus  Bassani, a longtime leader and visionary in the pharmacy compounding  industry who has recently assumed the role of chief executive officer  of the Professional Compounding Centers of America, PCCA.

Mr. Bassani earned his doctor of pharmacy degree from Drake  University's College of Pharmacy and Health Sciences. Since then, he  has been invaluable in various settings within the pharmaceutical  industry.

Mr. Bassani embraces opportunities to give back, teaching  extemporaneous compounding principles to pharmacy students at Drake  University.

Mr. Bassani has been with PCCA since September 2002, actively  participating in legislative, regulatory, and public affairs  initiatives. At PCCA, he has been a visionary, contributing extensively  to the organization's scientific, technical, and strategic pursuits.

In addition to his outstanding work with PCCA, Mr. Bassani has  previously served on the United States Pharmacopeia Compounding Expert  Committee.

Mr. Speaker, I congratulate Mr. Bassani on this exciting achievement,  and I wish him the best in his new role.